Good company now transitioning to established mid-size pharma - Director bei BeOne: Mitarbeiterbewertung

4.0
25. Dez. 2022
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Pipeline, good quality recent hires

Kontras

Establishing better processes needed and cleaning out a few legacy employees who are not a good fit for the next stage of company’s growth/stage.

Mehr Bewertungen zu BeOne entdecken

5.0
24. Apr. 2026
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.

Kontras

Fast timelines and global expansion may translate into heavy workload and urgency

3.0
5. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Good wprk tee lunch and free commute

Kontras

Bad work but bad commute to work

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle